EFFECTS OF SEMAGLUTIDE ON CHRONIC KIDNEY DISEASE OUTCOMES: A POST HOC POOLED ANALYSIS FROM THE SUSTAIN 6 AND PIONEER 6 TRIALS

被引：0
|
作者：
Tuttle, Katherine
Cherney, David
Hadjadj, Samy
Idorn, Thomas
Mosenzon, Ofri
Perkovic, Vlado
Rasmussen, Soren
Wolthers, Benjamin
Bain, Stephen C.
机构：
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2020年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
MO051
引用
收藏
页码：152 / 152
页数：1
相关论文
共 50 条
  • [1] Cardiovascular, Metabolic and Safety Outcomes With Semaglutide by Age: A Post Hoc Analysis of SUSTAIN 6 and PIONEER 6
    Petrie, Mark
    Bain, Stephen
    Hoff, Soren Tetens
    Johansen, Nicklas
    Rasmussen, Soren
    Vilsboell, Tina
    Husain, Mansoor
    CIRCULATION, 2021, 144
  • [2] REDUCTION IN THE RATE OF EGFR DECLINE WITH SEMAGLUTIDE VS PLACEBO: A POST HOC POOLED ANALYSIS OF SUSTAIN 6 AND PIONEER 6
    Tuttle, Katherine
    Cherney, David
    Hadjadj, Samy
    Idorn, Thomas
    Mosenzon, Ofri
    Perkovic, Vlado
    Rasmussen, Soren
    Wolthers, Benjamin
    Bain, Stephen C.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 183 - 183
  • [3] Cardiovascular, Metabolic, and Safety Outcomes with Semaglutide by Baseline Age: Post Hoc Analysis of SUSTAIN 6 and PIONEER 6
    Stephen C. Bain
    Nicolas Belmar
    Søren T. Hoff
    Mansoor Husain
    Søren Rasmussen
    Tina Vilsbøll
    Mark C. Petrie
    Diabetes Therapy, 2025, 16 (1) : 15 - 28
  • [4] Effects of liraglutide and semaglutide on stroke subtypes in patients with type 2 diabetes: a post hoc analysis of the LEADER, SUSTAIN 6 and PIONEER 6 trials
    Strain, W. D.
    Holst, A. G.
    Rasmussen, S.
    Saevereid, H. A.
    James, M. A.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S130 - S131
  • [5] Effects of liraglutide and semaglutide on stroke subtypes in patients with type 2 diabetes: a post hoc analysis of the LEADER, SUSTAIN 6 and PIONEER 6 trials
    Strain, W. D.
    Holst, A. G.
    Rasmussen, S.
    Saevereid, H. A.
    James, M. A.
    EUROPEAN HEART JOURNAL, 2020, 41 : 2424 - 2424
  • [6] Effects of Semaglutide on Stroke Subtypes in Type 2 Diabetes: Post Hoc Analysis of the Randomized SUSTAIN 6 and PIONEER 6
    Strain, W. David
    Frenkel, Ofir
    James, Martin A.
    Leiter, Lawrence A.
    Rasmussen, Soren
    Rothwell, Peter M.
    Ripa, Maria Sejersten
    Truelsen, Thomas C.
    Husain, Mansoor
    STROKE, 2022, 53 (09) : 2749 - 2757
  • [7] Effect of semaglutide on major adverse cardiovascular events by baseline kidney parameters in participants with type 2 diabetes and at high risk of cardiovascular disease: SUSTAIN 6 and PIONEER 6 post hoc pooled analysis
    Peter Rossing
    Stephen C. Bain
    Heidrun Bosch-Traberg
    Ekaterina Sokareva
    Hiddo J. L. Heerspink
    Søren Rasmussen
    Linda G. Mellbin
    Cardiovascular Diabetology, 22
  • [8] Effect of semaglutide on major adverse cardiovascular events by baseline kidney parameters in participants with type 2 diabetes and at high risk of cardiovascular disease: SUSTAIN 6 and PIONEER 6 post hoc pooled analysis
    Rossing, Peter
    Bain, Stephen C.
    Bosch-Traberg, Heidrun
    Sokareva, Ekaterina
    Heerspink, Hiddo J. L.
    Rasmussen, Soren
    Mellbin, Linda G.
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [9] Semaglutide reduces cardiovascular events regardless of metformin use: a post hoc subgroup analysis of SUSTAIN 6 and PIONEER 6
    Husain, Mansoor
    Consoli, Agostino
    De Remigis, Alessandra
    Meyer, Anna Sina Pettersson
    Rasmussen, Soren
    Bain, Stephen
    CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [10] Effect of semaglutide versus placebo on cardiovascular outcomes by baseline HbA1c: SUSTAIN 6 and PIONEER 6 post hoc analysis
    Mellbin, L. G.
    Bhatt, D. L.
    David, J. -P.
    Petrie, M. C.
    Rasmussen, S.
    Schytz, P. A.
    Vilsboll, T.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S304 - S305
12345